PLASMONIC PHOTOTHERMAL THERAPY IN EXPERIMENTAL ONCOLOGY: PROBLEMS AND PROSPECTS
Journal: Cardiometry
Year: 2022

Despite great advances in the treatment of cancer, the effectiveness of standard chemotherapy and radiation therapy for some malignant neoplasms remains insufficient. Plasmonic photothermal therapy (PPT) with plasmon resonance gold nanoparticles has been an intensively researched area in therapy in recent years [1, 2]. Successful PPT with nanoparticles for tumor treatment requires solving a number of problems associated with the potential toxicity and the bio-distribution of nanoparticles, inclu